Insider sales are small relative to market cap and likely routine post-exercise liquidity. No bearish signal from this cluster alone. Monitor for any upcoming news (e.g., trial data, partnership) that could explain timing, but the dollar amount does not warrant a directional trade.
IMNM drugs
IMNM drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 11 $26.25entry
- T+1 · 3mo ago +6.63%α +6.38% · $27.99
- T+5 · 3mo ago +4.99%α +5.39% · $27.56
- T+20 · 2mo ago −0.50%α +0.56% · $26.12
- T+60 · 13d ago −25.64%α −25.15% · $19.52
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at Immunome (IMNM) sold a total of ~$2.82M in shares over a 7-day window. The CBO sold $2.27M after exercising options, and a director sold $543K. Relative to IMNM's $2.8B market cap, these sales are ~0.1% and are routine in size, likely driven by option exercise and diversification rather than a negative signal.
Key Financial Metrics
Key Facts
- CBO Horn Kinney sold 90,616 shares at $25.09 for $2.27M on Aug 4, following derivative exercises at lower strike prices.
- Director Barchas Isaac sold 20,840 shares at $26.06 for $543K on Aug 6.
- Total open-market sales represent ~$2.82M, or ~0.1% of IMNM's $2.8B market cap.
- No other contextual filings (earnings, press releases, restatements) accompany this cluster.
Financial Impact
Sales of ~$2.82M, ~0.1% of market cap, immaterial
Risk Factors
- Market may misinterpret cluster selling as negative, but the size is too small to move the stock.
- CBO sold a sizable portion of exercised options, which could signal mild caution if repeated at higher volumes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IMNM-1786392651778 |
Track record
20 reports on IMNM
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +26.53% at T+60 after the May 28, 2026 report. 6 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $18.39 Now $17.61 −4.24% settles Feb 12
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago S-3ASR Neutral 3/10 Entry $18.65 Now $17.61 −5.58% settles Feb 8
- Nov 9, 20267d ago 8-K Bearish 5/10 Entry $18.65 Now $17.61 +5.58% settles Feb 8
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $18.21 Now $17.61 −3.29% settles Jan 28
- Oct 16, 20264w ago ANALYST-UPGRADE Bullish 4/10 Entry $16.47 Now $17.61 +6.92% settles Jan 13
- Oct 5, 20266w ago 8-K Bullish 6/10 Entry $21.17 Now $17.61 −16.82% settles Dec 30
- Oct 1, 20266w ago ANALYST-UPGRADE Bearish 4/10 Entry $20.89 Now $17.61 +15.70% settles Dec 28
- Sep 21, 20268w ago ANALYST-UPGRADE Bullish 4/10 Entry $25.07 Now $17.61 −29.76% settles Dec 15
- Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $26.42 to $18.71 Now $17.61 −33.35% ▼ −29.18% −23.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers